| Product Code: ETC7646871 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Breast Cancer Liquid Biopsy Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Breast Cancer Liquid Biopsy Market - Industry Life Cycle |
3.4 Israel Breast Cancer Liquid Biopsy Market - Porter's Five Forces |
3.5 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By Circulating Biomarkers, 2021 & 2031F |
3.7 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume Share, By End Users, 2021 & 2031F |
4 Israel Breast Cancer Liquid Biopsy Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of breast cancer in Israel |
4.2.2 Growing awareness about the benefits of liquid biopsy over traditional biopsy methods |
4.2.3 Technological advancements in liquid biopsy techniques |
4.2.4 Favorable government initiatives and funding for breast cancer research and healthcare infrastructure |
4.3 Market Restraints |
4.3.1 High cost associated with liquid biopsy tests |
4.3.2 Limited reimbursement policies for liquid biopsy procedures |
4.3.3 Lack of skilled healthcare professionals for conducting liquid biopsy tests |
4.3.4 Regulatory challenges and approval process for new liquid biopsy products |
5 Israel Breast Cancer Liquid Biopsy Market Trends |
6 Israel Breast Cancer Liquid Biopsy Market, By Types |
6.1 Israel Breast Cancer Liquid Biopsy Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Consumables, 2021- 2031F |
6.1.4 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Kits, 2021- 2031F |
6.2 Israel Breast Cancer Liquid Biopsy Market, By Circulating Biomarkers |
6.2.1 Overview and Analysis |
6.2.2 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Extracellular Vesicles (EVs), 2021- 2031F |
6.2.3 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Cell-free DNA (cfDNA), 2021- 2031F |
6.2.4 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By ctRNA, 2021- 2031F |
6.2.5 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Circulating Tumor Cells (CTCs), 2021- 2031F |
6.2.6 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By cfRNA, 2021- 2031F |
6.2.7 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Israel Breast Cancer Liquid Biopsy Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3.3 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Physician Laboratories, 2021- 2031F |
6.3.5 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Reference Laboratories, 2021- 2031F |
6.3.6 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Public Health Laboratories, 2021- 2031F |
6.3.7 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Research Institutes, 2021- 2031F |
6.3.8 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
6.3.9 Israel Breast Cancer Liquid Biopsy Market Revenues & Volume, By Pathology Laboratories, 2021- 2031F |
7 Israel Breast Cancer Liquid Biopsy Market Import-Export Trade Statistics |
7.1 Israel Breast Cancer Liquid Biopsy Market Export to Major Countries |
7.2 Israel Breast Cancer Liquid Biopsy Market Imports from Major Countries |
8 Israel Breast Cancer Liquid Biopsy Market Key Performance Indicators |
8.1 Average turnaround time for liquid biopsy test results |
8.2 Rate of adoption of liquid biopsy in breast cancer diagnostics |
8.3 Number of research studies and clinical trials using liquid biopsy techniques |
8.4 Patient satisfaction and feedback on the experience of undergoing liquid biopsy test |
8.5 Accuracy and sensitivity of liquid biopsy compared to traditional biopsy methods |
9 Israel Breast Cancer Liquid Biopsy Market - Opportunity Assessment |
9.1 Israel Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Breast Cancer Liquid Biopsy Market Opportunity Assessment, By Circulating Biomarkers, 2021 & 2031F |
9.3 Israel Breast Cancer Liquid Biopsy Market Opportunity Assessment, By End Users, 2021 & 2031F |
10 Israel Breast Cancer Liquid Biopsy Market - Competitive Landscape |
10.1 Israel Breast Cancer Liquid Biopsy Market Revenue Share, By Companies, 2024 |
10.2 Israel Breast Cancer Liquid Biopsy Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here